Literature DB >> 2972724

Clustering of ligand on the surface of a particle enhances adhesion to receptor-bearing cells.

A Hermanowski-Vosatka1, P A Detmers, O Götze, S C Silverstein, S D Wright.   

Abstract

Human leukocytes express a receptor that mediates the binding of cells and particles coated with C3bi, a fragment of the third component of complement. Previous data indicate that the capacity of this receptor to mediate binding is regulated by changes in its aggregation state. Randomly distributed receptors bind ligand very inefficiently, but stimulation of polymorphonuclear leukocytes with phorbol esters causes a ligand-independent clustering of the receptors in the membrane, and the clustered receptors avidly bind C3bi-coated cells (1). We examined whether the aggregation state of surface-bound ligands also affects the efficiency of binding between receptors and ligands. We found that erythrocytes bearing C3bi in clusters were bound by both macrophages and polymorphonuclear leukocytes far more avidly than erythrocytes bearing the same number of ligands in random array. We made similar observations with erythrocytes coated with C3b, a ligand that is recognized by a separate receptor. Our observations show that the ability of a receptor-bearing cell to bind particles coated with the corresponding ligands is dramatically affected by the distribution of ligand on the surface of the particle. Cell-cell interactions may thus be regulated by alterations in the two-dimensional distribution of receptors and ligands on opposing cell surfaces.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972724

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Cross-linking of cell surface receptors enhances cooperativity of molecular adhesion.

Authors:  A Chen; V T Moy
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

Review 2.  Extracellular matrix molecules and their receptors: functions in neural development.

Authors:  L F Reichardt; K J Tomaselli
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

3.  Binding of Cryptococcus neoformans to heterologously expressed human complement receptors.

Authors:  S M Levitz; A Tabuni; T R Kozel; R S MacGill; R R Ingalls; D T Golenbock
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.

Authors:  R G Sitrin; R F Todd; E Albrecht; M R Gyetko
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

Review 5.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen.

Authors:  J D Loike; B Sodeik; L Cao; S Leucona; J I Weitz; P A Detmers; S D Wright; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 7.  Complement Receptors in Myeloid Cell Adhesion and Phagocytosis.

Authors:  Michael L Dustin
Journal:  Microbiol Spectr       Date:  2016-11

8.  Beta-1 integrin-mediated adhesion may be initiated by multiple incomplete bonds, thus accounting for the functional importance of receptor clustering.

Authors:  Joana Vitte; Anne-Marie Benoliel; Philippe Eymeric; Pierre Bongrand; Anne Pierres
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

9.  In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation.

Authors:  H A Lehr; F Krombach; S Münzing; R Bodlaj; S I Glaubitt; D Seiffge; C Hübner; U H von Andrian; K Messmer
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

10.  Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.

Authors:  S M Levitz; A Tabuni
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.